AbCellera Biologics(ABCL)
$11.49-0.13 (-1.12%)
ABCL
AbCellera Biologics earnings date
$11.49
At close:-0.13 (-1.12%)
Want to see ABCL full AI Analyst Report?
AbCellera Biologics (ABCL) Q2 2022 Earnings Report
2,564 Followers
ABCL Q2 2022 EPS Results
- Actual EPS
- -$0.02
- Consensus EPS
- $0.00
- Beat/Miss
- Missed by -$0.02
- One Year Ago EPS
- -$0.01
ABCL Q2 2022 Revenue Results
- Actual Revenue
- $45.92M
- Expected Revenue
- $53.59M
- Beat/Miss
- Missed by -$7.67M
- YoY Revenue Growth
- +66.11%
Earnings Announcement Details
- Quarter
- Q2 2022
- Date
- 08/09/2022
- Time
- After Close
- Conference Call
- Tuesday, August 9, 2022
ABCL Upcoming Earnings
AbCellera Biologics's next earnings date is estimated for February 23, 2027, based on past reporting schedules.
Q2 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
ABCL Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 23, 2027 | 2026 (Q4) | -0.15- | -0.03 | ― | ― |
| Nov 09, 2026 | 2026 (Q3) | -0.17-0.13 | -0.19 | 31.58% (+0.06) | |
| Aug 05, 2026 | 2026 (Q2) | -0.16-0.18 | -0.12 | -50.00% (-0.06) | |
| May 11, 2026 | 2026 (Q1) | -0.17-0.14 | -0.15 | 6.67% (+0.01) | |
| Feb 24, 2026 | 2025 (Q4) | -0.13-0.03 | -0.12 | 75.00% (+0.09) | |
| Nov 06, 2025 | 2025 (Q3) | -0.14-0.19 | -0.17 | -11.76% (-0.02) | |
| Aug 07, 2025 | 2025 (Q2) | -0.13-0.12 | -0.13 | 7.69% (+0.01) | |
| May 08, 2025 | 2025 (Q1) | -0.14-0.15 | -0.14 | -7.14% (-0.01) | |
| Feb 27, 2025 | 2024 (Q4) | -0.13-0.12 | -0.16 | 25.00% (+0.04) | |
| Nov 04, 2024 | 2024 (Q3) | -0.12-0.17 | -0.1 | -70.00% (-0.07) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
